Tag: carotid revascularisation
Contego Medical’s Neuroguard IEP system receives US FDA approval for carotid...
Contego Medical today announced the US Food and Drug Administration's (FDA) premarket approval (PMA) of the Neuroguard IEP system for carotid revascularisation.
The company shares...
InspireMD congratulates CREST-2 investigators on completion of trial enrolment
InspireMD today congratulated the lead investigators on the completion of enrolment in the CREST-2 clinical trials.
The CGuard embolic prevention stent system (EPS), utilising...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
No relationship found between DW-MRI lesions and long-term stroke risk following...
A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid...
Rates of stroke, death and myocardial infarction post-TCAR do not differ...
While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery...
Interim data find “no evidence of benefit” for carotid revascularisation additional...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
